Linyi, China

Lili Zhao

USPTO Granted Patents = 1 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Lili Zhao: Pioneering Bispecific Antibody Research

Introduction: Lili Zhao, an accomplished inventor from Linyi, China, has made significant contributions to the field of biotechnology. With her innovative spirit and dedication to research, she has developed a groundbreaking patent that holds promise for cancer treatment. As part of the team at Shandong New Time Pharmaceutical Co., Ltd., Lili continues to push the boundaries of scientific advancement.

Latest Patents: Lili Zhao is the inventor of a noteworthy patent titled "Bispecific antibody binding BCMA and CD3." This invention encompasses methods and applications for a bispecific antibody that uniquely targets the CD3 surface antigen on immune cells and the BCMA antigen found on tumor cells. The antibody is designed to bind with high affinity to human CD3, facilitating T cell proliferation and enhancing tumor cell death. This innovative approach holds great potential for mediating specific killing of target cells in controlled laboratory settings.

Career Highlights: With her educational background and expertise, Lili Zhao has established herself as a key player in the field of pharmaceutical research. Her work at Shandong New Time Pharmaceutical Co., Ltd. underscores her commitment to developing advanced therapeutic solutions. The patent she secured is a testament to her innovative thinking and perseverance in tackling complex health challenges.

Collaborations: Lili has worked alongside talented colleagues, including Qiang Li and Shixiang Jia. Together, they share a vision for advancing cancer therapeutics and enhancing the efficacy of treatments through innovative scientific methods. Their collaboration exemplifies the power of teamwork in driving significant progress within the research community.

Conclusion: Lili Zhao's contributions to biopharmaceutical innovation are noteworthy. Her invention of a bispecific antibody demonstrates her commitment to harnessing the potential of immune cells in the fight against cancer. As she continues her work at Shandong New Time Pharmaceutical Co., Ltd., Lili’s research may pave the way for more effective therapies, making her a key figure in the landscape of modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…